论文部分内容阅读
TNT(Treating to New Targets)研究亚组分析发现,相对于低剂量,高剂量阿托伐他汀可显著降低稳定型冠心病(CHD)患者的心衰住院率,对既往HF的患者效果尤为明显。
A subgroup analysis of the Treating to New Targets (TNT) study found that high-dose atorvastatin significantly reduced hospitalization for heart failure in patients with stable coronary heart disease (CHD), especially in patients with previous HF, compared with low-dose and high-dose atorvastatin.